Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
39,15 HKD | +1,56% | +17,92% | -8,42% |
17/04 | Innovent benoemt Dr. Nageatte Ibrahim tot Oncology Chief Medical Officer | CI |
02/04 | Hutchmed aanvraag voor behandeling van endometriumkanker geaccepteerd voor beoordeling | AN |
Vakgebied
Aantal werknemers: 4 872
Verkoop per activiteit
HKD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100,0
%
| 5 146 | 100,0 % | 5 299 | 100,0 % | +2,97% |
Verkoop per regio
HKD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
China
90,7
%
| 4 782 | 92,9 % | 4 806 | 90,7 % | +0,50% |
United States
9,0
%
| 315 | 6,1 % | 478 | 9,0 % | +51,58% |
Indonesia
0,3
%
| 8 | 0,2 % | 15 | 0,3 % | +87,12% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
De Chao Yu
CEO | Chief Executive Officer | 61 | 28-04-11 |
Fei You
DFI | Director of Finance/CFO | 45 | 05/02 |
Yong-Jun Liu
PSD | President | - | 15-10-20 |
Ghang Shou Gao
CTO | Chief Tech/Sci/R&D Officer | - | - |
Qin Wei Zhou
COO | Chief Operating Officer | 61 | 16-06-16 |
Hao Xi Ede
BRD | Director/Board Member | 65 | 05-06-17 |
Vivian Zhang
HRO | Human Resources Officer | - | 01-03-12 |
Blake Salisbury
PRN | Corporate Officer/Principal | - | 01-03-16 |
Yan Ju Wang
SEC | Corporate Secretary | 36 | 01-10-15 |
Lok Yee Chan
SEC | Corporate Secretary | 35 | 04-06-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gary Zieziula
BRD | Director/Board Member | 69 | 31-05-22 |
Charles Cooney
BRD | Director/Board Member | 80 | 18-10-15 |
De Chao Yu
CEO | Chief Executive Officer | 61 | 28-04-11 |
I Yin Hsu
BRD | Director/Board Member | 50 | 18-10-18 |
Hao Xi Ede
BRD | Director/Board Member | 65 | 05-06-17 |
Kai Xian Chen
BRD | Director/Board Member | 79 | 18-10-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 622 682 897 | 1 509 307 058 ( 93,01 %) | 0 | 93,01 % |
Bedrijfsgegevens
Innovent Biologics, Inc.
168 Dongping Street Suzhou Industrial Park
215123, Suzhou
+86 512 6956 6088
http://www.innoventbio.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-8,42% | 7,99 mld. | |
-4,66% | 87,53 mld. | |
+2,63% | 40,42 mld. | |
-20,11% | 29,48 mld. | |
+57,86% | 25,43 mld. | |
-17,88% | 11,49 mld. | |
-44,02% | 11,3 mld. | |
-9,14% | 11,1 mld. | |
+5,24% | 8,75 mld. | |
+2,18% | 7,67 mld. |
- Beurs
- Aandelen
- Koers 1801
- Onderneming Innovent Biologics, Inc.